ImmuCell Quick Ratio 2010-2025 | ICCC
Historical quick ratio values for ImmuCell (ICCC) over the last 10 years.
| ImmuCell Quick Ratio Historical Data | |||
|---|---|---|---|
| Date | Current Assets - Inventory | Current Liabilities | Quick Ratio |
| 2025-03-31 | $0.01B | $0.00B | 2.22 |
| 2024-12-31 | $0.01B | $0.00B | 1.80 |
| 2024-09-30 | $0.01B | $0.00B | 1.44 |
| 2024-06-30 | $0.00B | $0.01B | 0.77 |
| 2024-03-31 | $0.00B | $0.00B | 1.00 |
| 2023-12-31 | $0.00B | $0.00B | 0.87 |
| 2023-09-30 | $0.01B | $0.00B | 1.38 |
| 2023-06-30 | $0.00B | $0.00B | 0.81 |
| 2023-03-31 | $0.01B | $0.00B | 1.54 |
| 2022-12-31 | $0.01B | $0.00B | 2.59 |
| 2022-09-30 | $0.01B | $0.00B | 4.09 |
| 2022-06-30 | $0.01B | $0.00B | 4.66 |
| 2022-03-31 | $0.02B | $0.00B | 5.78 |
| 2021-12-31 | $0.01B | $0.00B | 5.20 |
| 2021-09-30 | $0.01B | $0.00B | 6.19 |
| 2021-06-30 | $0.01B | $0.00B | 6.45 |
| 2021-03-31 | $0.01B | $0.00B | 4.62 |
| 2020-12-31 | $0.01B | $0.00B | 4.55 |
| 2020-09-30 | $0.01B | $0.00B | 4.36 |
| 2020-06-30 | $0.01B | $0.00B | 3.97 |
| 2020-03-31 | $0.01B | $0.00B | 5.02 |
| 2019-12-31 | $0.01B | $0.00B | 4.28 |
| 2019-09-30 | $0.01B | $0.00B | 4.91 |
| 2019-06-30 | $0.01B | $0.00B | 6.76 |
| 2019-03-31 | $0.01B | $0.00B | 6.25 |
| 2018-12-31 | $0.00B | $0.00B | 1.59 |
| 2018-09-30 | $0.00B | $0.00B | 2.06 |
| 2018-06-30 | $0.00B | $0.00B | 2.91 |
| 2018-03-31 | $0.00B | $0.00B | 3.17 |
| 2017-12-31 | $0.01B | $0.00B | 2.64 |
| 2017-09-30 | $0.00B | $0.00B | 0.99 |
| 2017-06-30 | $0.01B | $0.00B | 1.28 |
| 2017-03-31 | $0.01B | $0.00B | 5.00 |
| 2016-12-31 | $0.01B | $0.00B | 5.94 |
| 2016-09-30 | $0.01B | $0.00B | 10.42 |
| 2016-06-30 | $0.01B | $0.00B | 10.79 |
| 2016-03-31 | $0.01B | $0.00B | 13.78 |
| 2015-12-31 | $0.01B | $0.00B | 8.84 |
| 2015-09-30 | $0.01B | $0.00B | 10.77 |
| 2015-06-30 | $0.01B | $0.00B | 8.55 |
| 2015-03-31 | $0.01B | $0.00B | 7.28 |
| 2014-12-31 | $0.01B | $0.00B | 4.48 |
| 2014-09-30 | $0.01B | $0.00B | 6.13 |
| 2014-06-30 | $0.01B | $0.00B | 6.50 |
| 2014-03-31 | $0.01B | $0.00B | 6.97 |
| 2013-12-31 | $0.01B | $0.00B | 9.54 |
| 2013-09-30 | $0.01B | $0.00B | 11.04 |
| 2013-06-30 | $0.01B | $0.00B | 7.20 |
| 2013-03-31 | $0.01B | $0.00B | 10.64 |
| 2012-12-31 | $0.01B | $0.00B | 8.58 |
| 2012-09-30 | $0.01B | $0.00B | 9.95 |
| 2012-06-30 | $0.01B | $0.00B | 10.79 |
| 2012-03-31 | $0.01B | $0.00B | 9.09 |
| 2011-12-31 | $0.01B | $0.00B | 8.64 |
| 2011-09-30 | $0.01B | $0.00B | 8.90 |
| 2011-06-30 | $0.01B | $0.00B | 6.57 |
| 2011-03-31 | $0.01B | $0.00B | 8.18 |
| 2010-12-31 | $0.01B | $0.00B | 10.31 |
| 2010-09-30 | $0.01B | $0.00B | 13.36 |
| 2010-06-30 | $0.01B | $0.00B | 15.44 |
| 2010-03-31 | $0.01B | $0.00B | 13.73 |
| 2009-12-31 | $0.01B | $0.00B | 14.50 |
| 2009-09-30 | $0.01B | $0.00B | 20.41 |
| 2009-06-30 | $0.01B | $0.00B | 15.13 |
| 2009-03-31 | $0.01B | $0.00B | 12.96 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $0.059B | $0.026B |
| ImmuCell Corp. is a biotechnology company striving to build shareholder value by commercializing proprietary technologies and helping dairy and beef producers and their veterinarians manage disease and reproduction in their herds. The company is also conducting an open label, efficacy study of DiffGAM, a human application of its milk-derived passive antibodytechnology for use as an alternative to antibiotics in the treatment and/or prevention of Clostridium difficile-associated diarrhea. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $222.716B | 26.12 |
| Boston Scientific (BSX) | United States | $157.517B | 37.62 |
| Stryker (SYK) | United States | $152.893B | 31.97 |
| EssilorLuxottica (ESLOY) | France | $140.240B | 0.00 |
| Medtronic (MDT) | Ireland | $118.558B | 16.81 |
| Lonza Group Ag (LZAGY) | Switzerland | $50.586B | 0.00 |
| Haleon (HLN) | United Kingdom | $44.070B | 25.15 |
| ResMed (RMD) | United States | $40.718B | 30.58 |
| GE HealthCare Technologies (GEHC) | United States | $35.587B | 16.90 |
| Agilent Technologies (A) | United States | $34.042B | 22.19 |
| Koninklijke Philips (PHG) | Netherlands | $26.981B | 17.85 |
| Terumo (TRUMY) | Japan | $25.673B | 33.35 |
| Insulet (PODD) | United States | $20.514B | 80.52 |
| Zimmer Biomet Holdings (ZBH) | United States | $18.786B | 12.06 |
| Baxter (BAX) | United States | $14.800B | 11.05 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $13.840B | 0.00 |
| Sunny Optical Technology (SNPTF) | China | $10.417B | 0.00 |
| Demant (WILYY) | Denmark | $8.633B | 0.00 |
| Bio-Rad Laboratories (BIO) | United States | $6.874B | 23.92 |
| Lantheus Holdings (LNTH) | United States | $4.995B | 12.60 |
| Perrigo (PRGO) | Ireland | $3.859B | 9.78 |
| Prestige Consumer Healthcare (PBH) | United States | $3.689B | 16.48 |
| Haemonetics (HAE) | United States | $3.629B | 16.53 |
| Shandong Weigao Medical Polymer (SHWGF) | China | $3.459B | 0.00 |
| Envista Holdings (NVST) | United States | $3.441B | 28.59 |
| ICU Medical (ICUI) | United States | $3.119B | 23.00 |
| LeMaitre Vascular (LMAT) | United States | $1.863B | 41.64 |
| QuidelOrtho (QDEL) | United States | $1.720B | 11.83 |
| AtriCure (ATRC) | United States | $1.571B | 0.00 |
| Acuren (TIC) | United States | $1.369B | 0.00 |
| Green Thumb Industries (GTBIF) | United States | $1.272B | 28.62 |
| AdaptHealth (AHCO) | United States | $1.259B | 12.78 |
| Phibro Animal Health (PAHC) | United States | $1.135B | 14.51 |
| BioLife Solutions (BLFS) | United States | $1.057B | 0.00 |
| Neogen (NEOG) | United States | $1.048B | 16.66 |
| Curaleaf Holdings (CURLF) | Canada | $0.933B | 0.00 |
| InMode (INMD) | Israel | $0.905B | 9.11 |
| Kestra Medical Technologies (KMTS) | United States | $0.847B | 0.00 |
| Valneva SE (VALN) | France | $0.660B | 0.00 |
| Maravai LifeSciences Holdings (MRVI) | United States | $0.632B | 0.00 |
| Evolus (EOLS) | United States | $0.596B | 0.00 |
| Tilray Brands (TLRY) | Canada | $0.581B | 0.00 |
| Owens & Minor (OMI) | United States | $0.576B | 4.78 |
| Surmodics (SRDX) | United States | $0.535B | 0.00 |
| CeriBell (CBLL) | United States | $0.533B | 0.00 |
| ZimVie (ZIMV) | United States | $0.524B | 23.81 |
| SNDL (SNDL) | Canada | $0.384B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.322B | 11.83 |
| SEMPERIT AG HLD (SEIGY) | Austria | $0.317B | 0.00 |
| Capricor Therapeutics (CAPR) | United States | $0.308B | 0.00 |
| Quanterix (QTRX) | United States | $0.304B | 0.00 |
| Sanuwave Health (SNWV) | United States | $0.298B | 0.00 |
| Cresco Labs (CRLBF) | United States | $0.295B | 0.00 |
| Cerus (CERS) | United States | $0.254B | 0.00 |
| Aurora Cannabis (ACB) | Canada | $0.250B | 74.00 |
| Biote (BTMD) | United States | $0.249B | 7.00 |
| Viemed Healthcare (VMD) | United States | $0.247B | 20.87 |
| Omeros (OMER) | United States | $0.245B | 0.00 |
| OraSure Technologies (OSUR) | United States | $0.245B | 0.00 |
| Brainsway (BWAY) | Israel | $0.224B | 59.15 |
| Sanara MedTech (SMTI) | United States | $0.222B | 0.00 |
| Verano Holdings (VRNOF) | United States | $0.217B | 0.00 |
| Canopy Growth (CGC) | Canada | $0.209B | 0.00 |
| Organigram Global (OGI) | Canada | $0.189B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.183B | 15.09 |
| Exagen (XGN) | United States | $0.180B | 0.00 |
| Vireo Growth (VREOF) | United States | $0.177B | 0.00 |
| High Tide (HITI) | Canada | $0.175B | 0.00 |
| TriSalus Life Sciences (TLSI) | United States | $0.164B | 0.00 |
| TerrAscend (TSNDF) | Canada | $0.132B | 0.00 |
| FitLife Brands (FTLF) | United States | $0.123B | 15.18 |
| Jushi Holdings (JUSHF) | United States | $0.107B | 0.00 |
| Jin Medical (ZJYL) | China | $0.100B | 0.00 |
| MacroGenics (MGNX) | United States | $0.100B | 0.00 |
| Fonar (FONR) | United States | $0.099B | 12.74 |
| Quipt Home Medical (QIPT) | United States | $0.095B | 0.00 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.090B | 0.00 |
| Safety Shot (SHOT) | United States | $0.081B | 0.00 |
| Zynex (ZYXI) | United States | $0.075B | 0.00 |
| Apyx Medical (APYX) | United States | $0.074B | 0.00 |
| Veru (VERU) | United States | $0.072B | 0.00 |
| InterCure (INCR) | Israel | $0.068B | 0.00 |
| Agape ATP (ATPC) | $0.064B | 0.00 | |
| Cytosorbents (CTSO) | United States | $0.057B | 0.00 |
| Modular Medical (MODD) | United States | $0.038B | 0.00 |
| United-Guardian (UG) | United States | $0.037B | 12.92 |
| Nephros (NEPH) | United States | $0.037B | 49.57 |
| Rockwell Medical (RMTI) | United States | $0.035B | 0.00 |
| Allurion Technologies (ALUR) | United States | $0.021B | 0.00 |
| INLIF (INLF) | $0.016B | 0.00 | |
| Flora Growth (FLGC) | United States | $0.015B | 0.00 |
| Meihua Medical Technologies (MHUA) | China | $0.013B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.012B | 0.00 |
| Senestech (SNES) | United States | $0.012B | 0.00 |
| IM Cannabis (IMCC) | Canada | $0.011B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.010B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.009B | 0.00 |
| Sharps Technology (STSS) | United States | $0.006B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.003B | 0.00 |
| Akanda (AKAN) | Canada | $0.002B | 0.00 |
| InVivo Therapeutics Holdings (NVIVQ) | United States | $0.000B | 0.00 |